skip to main content
Primo Search
Search in: Busca Geral

Productivity costs associated with metastatic breast cancer in younger, midlife, and older women

Trogdon, Justin G. ; Liu, Xuejun ; Reeder‐Hayes, Katherine E. ; Rotter, Jason ; Ekwueme, Donatus U. ; Wheeler, Stephanie B.

Cancer, 2020-09, Vol.126 (18), p.4118-4125 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
  • Título:
    Productivity costs associated with metastatic breast cancer in younger, midlife, and older women
  • Autor: Trogdon, Justin G. ; Liu, Xuejun ; Reeder‐Hayes, Katherine E. ; Rotter, Jason ; Ekwueme, Donatus U. ; Wheeler, Stephanie B.
  • Assuntos: Age ; Breast cancer ; Costs ; economic burden ; Market value ; Metastases ; Metastasis ; metastatic ; Oncology ; Polls & surveys ; Population studies ; Productivity ; productivity costs ; Vital statistics ; years of potential life lost
  • É parte de: Cancer, 2020-09, Vol.126 (18), p.4118-4125
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: Background The objective of the current study was to estimate productivity costs due to metastatic breast cancer (mBC) via productive time lost among survivors and potential life‐years lost from premature mortality among 3 age groups: younger (aged 18‐44 years), midlife (aged 45‐64 years), and older (aged ≥65 years) women. Methods The authors estimated the number of work and home productivity days missed due to mBC by age group using data from the 2000 to 2016 National Health Interview Survey. Years of potential life lost (YPLL) due to mBC were calculated for each age group using 2015 National Vital Statistics System data. The authors valued both sources of lost productivity time using the Current Population Survey and prior studies. Results The per‐woman value of lost productive days (work and home) due to mBC ranged from $680 for older women to $5169 for younger women. In 2015, the value of lost work and home productivity days associated with mBC nationally was $67 million for younger women, $246 million for midlife women, and $66 million for older women. YPLL were highest among midlife women (403,786 life‐years), followed by older women (248,522 life‐years) and younger women (95,943 life‐years). Midlife women were found to have the highest market value of YPLL ($4.1 billion), followed by younger women ($1.6 billion) and older women ($527 million). Conclusions The results of the current study demonstrated that mBC generates a high economic burden through lost productivity, especially among midlife women. Herein, the authors report that metastatic breast cancer was associated with $18.2 billion in lost productivity nationally in 2015. The results of the current study highlight the potential benefit of supportive resources to help women with metastatic breast cancer guard against potentially severe cancer‐related financial losses for themselves and others within their households.
  • Editor: United States: Wiley Subscription Services, Inc
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.